News list for " windtree"
Nasdaq plans to delist BNB treasury company Windtree Therapeutics (ticker: WINT) after failing to comply with Nasdaq Listing Rule 5550 (a) (2), which requires minimum bids for shares to remain above $1. Windtree confirmed its non-compliance in a filing with the Securities Supervision Commission.
纳斯达克计划摘牌BNB财库公司Windtree Therapeutics（股票代码：WINT），原因是公司未能遵守纳斯达克上市规则5550(a)(2)——即股票最低竞价需维持在1美元以上。Windtree在向美国证监会提交的文件中确认了其不合规状况。
Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced that it has signed a common stock purchase agreement of up to $500 million to establish an equity credit line (ELOC), in addition to an additional stock purchase agreement valued at $20 million with Build and Build Corp. The total financing size is up to $520 million, of which 99% will be used to purchase BNB. The company plans to officially start using funds after obtaining shareholder approval to increase the number of common...
纳斯达克上市生物技术公司 Windtree Therapeutics（WINT）宣布，已签署最多 5 亿美元的普通股购买协议，用于建立股权信用额度（ELOC），此外，该公司还与 Build and Build Corp 签署了一份价值 2000 万美元的额外股票购买协议。 此次总融资规模最高达 5.2 亿美元，其中 99% 的资金将用于购买 BNB。公司计划在获得股东批准增加普通股授权数量后正式启动资金动用。
纳斯达克上市公司 Windtree Therapeutics (WINT) 宣布与 Build and Build Corp 达成 6000 万美元证券购买协议，未来有望获得高达 1.4 亿美元的额外资金，总认购额可达 2 亿美元。该融资将主要用于启动币安生态代币 (BNB) 资产储备战略。
